
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R2032608 | GSK-LSD1 2HCl | GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 n |
| R2032609 | Afuresertib(GSK2110183) | GSK2110183 analog 1 is the structural analogue of GSK2110183. |
| R2032610 | ORG27569 | Org 27569 is a potent CB1 receptor allosteric modulator, which increases agonist |
| R2032611 | NVP-231 | NVP-231 is a potent, specific, and reversible CerK inhibitor(IC50=12±2 nM) that |
| R2032612 | b-AP15;NSC 687852) | b-AP15 is a specific inhibitor of the deubiquitinating enzymes UCHL5 and Usp14. |
| R2032613 | AZ5104 | AZ-5104 is an active, demethylated metabolite of AZD 9291.AZ-5104 is an EGFR inh |
| R2032614 | Cathepsin S inhibitor | LY 3000328 is a potent and selective Cathepsin S (Cat S) inhibitor with IC50s of |
| R2032615 | GSK1014802(CNV1014802) | Raxatrigine (GSK-1014802) is a novel small molecule state-dependent sodium chann |
| R2032616 | GSK503 | GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Ki |
| R2032617 | GSK650394 | GSK 650394 is a novel SGK inhibitor with IC50 of 62 nM and 1 |
| R2032618 | INCB032304 | INCB032304 is a pharmaceutical intermediate. |
| R2032619 | KRCA-0008 | KRCA-0008 is a potent and selective ALK/Ack1 inhibitor with IC50 of 12 nM/4 nM f |
| R2032620 | LY2484595 | Evacetrapib is a potent and selective of CETP inhibitor, which inhibits human re |
| R2032621 | RGB-286638 | RGB-286638 is a CDK inhibitor that inhibits the kinase activity of cyclin T1-CDK |
| R2032622 | TG003 | TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 |
| R2032623 | Thiamet G | Thiamet G is a potent and selective inhibitor of O-GlcNAcase (OGA), which acts t |
| R2032624 | UNC0642 | UNC0642 is a potent and selective G9a/GLP inhibitor, with an IC50 of less than 2 |
| R2032625 | z-devd-fmk | Z-DEVD-FMK is a specific and irreversible caspase-3 inhibitor with IC50 of 18 μM |
| R2032626 | BMS663068;Fostemsavir(BMS-663068) | Fostemsavir (BMS-663068) is the phosphonooxymethyl prodrug of BMS-626529.Fostems |
| R2032627 | BX517(PDK1 inhibitor2) | BX517 is a potent and selective inhibitor of PDK1 with IC50 of 6 nM. |
| R2032628 | Darapladib(SB-480848) | Darapladib is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp- |
| R2032629 | GDC-0349 | GDC-0349 is a potent and selective ATP-competitive mTOR inhibitor with a Ki of 3 |
| R2032630 | GSK-J4 | GSK-J4 is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and U |
| R2032631 | GSK2838232 | |
| R2032632 | KN-92 hydrochloride | KN-92 hydrochloride is an inactive derivative of KN-93.KN-93 is a selective inhi |